Navigation Links
Ex-Allergan Vice President Joins Kalologie Skincare Board of Directors
Date:3/19/2008

SANTA MONICA, Calif., March 19 /PRNewswire/ -- Kalologie Skincare today announced that Niv Edward Caviar, Executive Vice President of La Jolla Pharmaceutical Company, was elected to Kalologie Skincare's board of directors. Mr. Caviar previously served as Vice President of Allergan Inc.

"Niv is a strong marketer with solid operational skills," said William Brennan, Kalologie's CEO. "We look forward to benefiting from Niv's unique insight in the growing aesthetic skin care industry."

"Over the past five years, Kalologie has positioned itself to become a leading provider of aesthetic skin care products and services," said Niv Edward Caviar. "I look forward to working with the Company to help facilitate future growth, especially through the company's physician-only franchise program."

At Allergan, Mr. Caviar was Vice-President of Business Development and then Vice-President and Head of Marketing for Medical Dermatology. In his latter role, Mr. Caviar led all operational and strategic marketing activities for Allergan's U.S medical dermatology franchise. Brands under his responsibility included Tazorac(R), Avage(R), and Botox(R) for Medical Dermatology uses. Mr. Caviar is presently Executive Vice-President and Chief Business and Financial Officer of La Jolla Pharmaceutical Co., a San Diego-based biotech company focused on developing innovative pharmaceutical products. La Jolla Pharmaceutical's leading product in development is Riquent(R) (abetimus sodium), which is currently being studied to help treat and maintain remission in patients with lupus renal disease.

Mr. Caviar received an M.B.A. from Harvard University and a B.S. in Mechanical Engineering from the U.S. Air Force Academy. Prior to his work at Allergan, Mr. Caviar served as a captain in the U.S. Air Force where he worked as a Solid Rocket Motor Engineer and was a Project Manager for the U.S. Space Command on both the Titan IV Rocket and the Space Shuttle Solid Rocket Motor Programs.

Founded in 2003, Kalologie is a chain of comprehensive, one-stop skin care clinics offering effective medical and aesthetic skin care treatments such as Botox(R), Juvederm, Restylane, IPL Photo Facials, Laser Hair Removal, Facials and Chemical Peels. In addition the Company offers a proprietary line of Kalologie-branded skin care products.

Kalologie Franchising, LLC, with headquarters in Santa Monica, California, is a solution-oriented skin care company offering a comprehensive approach to address the unique challenges of each individual's skin. http://www.kalologie.com

For press inquiries, please contact Sarah Lopez; sarah_lopez@kalologie.com; (310) 961-2077.

This release was issued through eReleases(TM). For more information, visit http://www.ereleases.com.


'/>"/>
SOURCE Kalologie Franchising, LLC
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Three CEOs and University President Named Winners of Greater Baltimore Committees 2008 Baltimore Region Bioscience Awards
2. Dr. Linda McAllister Joins Arbor Vita Corporation as Vice President of Diagnostics
3. iCAD Appoints John DeLucia as Vice President of Quality Assurance and Regulatory Affairs
4. Cato Research Names John Cline as President
5. Matthew B. Potter Joins Pressure BioSciences, Inc. as Vice President of Sales
6. febit Appoints Michelle Lyles, Ph.D., Vice President, Marketing and Sales
7. Elusys Therapeutics Appoints Robert Gundel as Vice President of Research
8. Bristol-Myers Squibb Board Elects Jean-Marc Huet Senior Vice President and Chief Financial Officer
9. MiMedx Announces Brian J. Splan as President
10. Michael J. Simms Joins Alexza Pharmaceuticals as Senior Vice President, Operations and Manufacturing
11. Onyx Pharmaceuticals Names N. Anthony Coles, M.D. as President, Chief Executive Officer and Member of its Board of Directors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/24/2017)... Inc. (NASDAQ: CBPO) ("China Biologic" or the "Company"), a leading ... financial results for the fourth quarter and fiscal year of ... Total sales in the fourth quarter of ... 13.6% in USD terms to $77.6 million from $68.3 million ... profit increased by 13.3% to $46.8 million from $41.3 million ...
(Date:2/23/2017)... Financial ... data, unaudited)Three Months Ended December 31,Twelve Months Ended December ... $           300$ ... Net Product Revenue 3539(10)%9498(4)%Kuvan Net ... Revenue  756025%297303(2)%Vimizim Net Product Revenue ...
(Date:2/23/2017)... , Feb. 23, 2017  In Atlanta, it seems ... fashion, and culture intertwine to create an expressive and dynamic ... reflect this energy and contribute to it. ... Hair Fairies seeks to carry on that tradition ... Atlanta salon is the newest of ...
(Date:2/23/2017)... ... February 23, 2017 , ... ... today that in a published evaluation of multiple immunoassay-based threat detection technologies ... of Energy Laboratory, PathSensors’ CANARY® biosensor threat detection technology was found to ...
Breaking Biology Technology:
(Date:2/2/2017)... 2, 2017   TapImmune, Inc. (NASDAQ: ... specializing in the development of innovative peptide and ... cancer and metastatic disease, announced today it has ... of a second clinical lot of TPIV 200, ... alpha. The manufactured vaccine product will be used ...
(Date:2/2/2017)... -- Central to its deep commitment to honor the ... Prize Foundation today announced the laureates of the ... in their respective fields of Life Sciences and ... recognized with the 2017 Japan Prize for original ... the advancement of science and technology, but also ...
(Date:1/31/2017)... , Jan. 31, 2017  Spero Therapeutics, LLC, ... for the treatment of bacterial infections, today announced ... antibacterial candidates from Pro Bono Bio Ltd (PBB) ... of multi-drug resistant forms of Gram-negative bacteria.   The ... Infectives Ltd, a PBB group company. ...
Breaking Biology News(10 mins):